CurrentEndo coverage · page 2 of 2
New England Journal of Medicine
Latest from New England Journal of Medicine
N Engl J Med
Arginine or Hypertonic Saline–Stimulated Copeptin to Diagnose AVP Deficiency
Diagnostic or prognostic studyPituitary
N Engl J Med
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Randomized controlled trialObesity
N Engl J Med
Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer
Randomized controlled trialEndocrine cancer
N Engl J Med
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
Randomized controlled trialT1D
N Engl J Med
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
Randomized controlled trialDiabetes in pregnancy
N Engl J Med
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Randomized controlled trialObesity
N Engl J Med
BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
Research articlePituitary
N Engl J Med
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Randomized controlled trialObesity
N Engl J Med
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Randomized controlled trialT2D & other
N Engl J Med
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Randomized controlled trialObesity
N Engl J Med
Cardiovascular Safety of Testosterone-Replacement Therapy
Randomized controlled trialReproductive endocrine
N Engl J Med
Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity
Research articleObesity
N Engl J Med
Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
Randomized controlled trialDiabetes in pregnancy
N Engl J Med
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
Randomized controlled trialTechnology
N Engl J Med
Psychosocial Functioning in Transgender Youth after 2 Years of Hormones
Cohort studyReproductive endocrine